Literature DB >> 1486888

Killing kinetics of five orally administered antibiotics at clinically achievable concentrations against Moraxella catarrhalis.

E Bingen1, F Bourgeois, H Chardon, C Doit, N Lambert-Zechovsky.   

Abstract

Time-kill kinetic studies were used to measure the bactericidal activity of amoxicillin/clavulanic acid (in a new form for pediatric use), cefaclor, cefuroxime, cefixime and erythromycin against 30 beta-lactamase producing Moraxella catarrhalis strains. Antibiotics were tested at the mean maximum serum concentration observed after administration of a standard dose and at 0.5 x Cmax, 0.33 x Cmax and 0.25 x Cmax. A 2 log10 reduction in colony counts was obtained with the Cmax of amoxicillin/clavulanic acid and cefixime after 5 h of incubation. After 24 h of incubation a decrease of 3 and 4 log was observed with cefixime and amoxicillin/clavulanic acid respectively. At 0.5 x Cmax and 0.33 x Cmax, bactericidal activity was obtained only with amoxicillin/clavulanic acid.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1486888     DOI: 10.1007/bf01962375

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  16 in total

1.  Branhamella catarrhalis as a cause of suppurative arthritis.

Authors:  S Izraeli; B Flasterstein; R Shamir; A Rachmel; M Nitzan; M Drucker; Z Samra
Journal:  Pediatr Infect Dis J       Date:  1989-04       Impact factor: 2.129

Review 2.  Antibiotic susceptibilities and drug resistance in Moraxella (Branhamella) catarrhalis.

Authors:  R J Wallace; D R Nash; V A Steingrube
Journal:  Am J Med       Date:  1990-05-14       Impact factor: 4.965

3.  Branhamella catarrhalis bacteremia in children.

Authors:  W A Bonadio
Journal:  Pediatr Infect Dis J       Date:  1988-10       Impact factor: 2.129

4.  Branhamella catarrhalis bacteremia in children.

Authors:  N Cimolai; R J Adderley
Journal:  Acta Paediatr Scand       Date:  1989-05

5.  Rate of bactericidal activity for Branhamella catarrhalis of a new macrolide, CP-62,993, compared with that of amoxicillin-clavulanic acid.

Authors:  E Yourassowsky; M P van der Linden; M J Lismont; F Crokaert; Y Glupczynski
Journal:  Chemotherapy       Date:  1988       Impact factor: 2.544

6.  Method of reliable determination of minimal lethal antibiotic concentrations.

Authors:  R D Pearson; R T Steigbigel; H T Davis; S W Chapman
Journal:  Antimicrob Agents Chemother       Date:  1980-11       Impact factor: 5.191

7.  Pharmacokinetics and bactericidal activity of cefuroxime axetil.

Authors:  C M Ginsburg; G H McCracken; M Petruska; K Olson
Journal:  Antimicrob Agents Chemother       Date:  1985-10       Impact factor: 5.191

8.  Kinetics of antimicrobial activity.

Authors:  B Vogelman; W A Craig
Journal:  J Pediatr       Date:  1986-05       Impact factor: 4.406

9.  Pharmacokinetic profile of cefixime in man.

Authors:  R D Faulkner; A Yacobi; J S Barone; S A Kaplan; B M Silber
Journal:  Pediatr Infect Dis J       Date:  1987-10       Impact factor: 2.129

10.  Pharmacology of erythromycin in infants and children.

Authors:  C M Ginsburg
Journal:  Pediatr Infect Dis       Date:  1986 Jan-Feb
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.